About Brinton Pharmaceuticals
Brinton Pharmaceuticals is a company based in Pune (India) founded in 2014 by Rahul Kundanmal Darda.. Brinton Pharmaceuticals has raised $16.93 million across 8 funding rounds from investors including BlackSoil, India Alternatives and IDBI trustee. The company has 508 employees as of April 02, 2024. Brinton Pharmaceuticals offers products and services including Therapeutic Solutions. Brinton Pharmaceuticals operates in a competitive market with competitors including LEO Pharma, Incyte, Formation Bio, Arcutis and DermBiont, among others.
- Headquarter Pune, India
- Employees 508 as on 02 Apr, 2024
- Founders Rahul Kundanmal Darda
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Brinton Pharmaceuticals Limited
- Date of Incorporation 27 Sep, 2013
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$18.15 M (USD)0as on Mar 31, 2023
-
Net Profit
$-405.16 K (USD)0as on Mar 31, 2023
-
EBITDA
$26.73 K (USD)0as on Mar 31, 2023
-
Total Equity Funding
$16.93 M (USD)
in 8 rounds
-
Latest Funding Round
$359.54 K (USD), Series B
Apr 30, 2024
-
Investors
BlackSoil
& 10 more
-
Employee Count
508
as on Apr 02, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brinton Pharmaceuticals
Brinton Pharmaceuticals offers a comprehensive portfolio of products and services, including Therapeutic Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products that redefine healing through scientific innovation.
Unlock access to complete
Unlock access to complete
Funding Insights of Brinton Pharmaceuticals
Brinton Pharmaceuticals has successfully raised a total of $16.93M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $359.54 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Series B — $359,535
-
First Round
First Round
(17 Feb 2015)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series B - Brinton Pharmaceuticals | Valuation |
investors |
|
| Apr, 2024 | Amount | Series B - Brinton Pharmaceuticals | Valuation |
investors |
|
| Aug, 2021 | Amount | Series B - Brinton Pharmaceuticals | Valuation | Winner Family Trust |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Brinton Pharmaceuticals
Brinton Pharmaceuticals has secured backing from 11 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include BlackSoil, India Alternatives and IDBI trustee. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
Private equity fund investing in healthcare and lifesciences in India.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Brinton Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Brinton Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Brinton Pharmaceuticals Comparisons
Competitors of Brinton Pharmaceuticals
Brinton Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LEO Pharma, Incyte, Formation Bio, Arcutis and DermBiont, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of drugs for treating dermatology diseases
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
Immunotherapeutic solutions for dermatological conditions are developed.
|
|
| domain | founded_year | HQ Location |
Microbial therapeutics for skin diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic options for chronic inflammatory disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Brinton Pharmaceuticals
Frequently Asked Questions about Brinton Pharmaceuticals
When was Brinton Pharmaceuticals founded?
Brinton Pharmaceuticals was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Brinton Pharmaceuticals located?
Brinton Pharmaceuticals is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Is Brinton Pharmaceuticals a funded company?
Brinton Pharmaceuticals is a funded company, having raised a total of $16.93M across 8 funding rounds to date. The company's 1st funding round was a Series B of $671.92K, raised on Feb 17, 2015.
How many employees does Brinton Pharmaceuticals have?
As of Apr 02, 2024, the latest employee count at Brinton Pharmaceuticals is 508.
What is the annual revenue of Brinton Pharmaceuticals?
Annual revenue of Brinton Pharmaceuticals is $18.15M as on Mar 31, 2023.
What does Brinton Pharmaceuticals do?
Brinton Pharmaceuticals was founded in 2014 in Pune, India, focusing on the pharmaceutical sector. Formulations are produced for clinical and cosmetic dermatology, respiratory care, gastroenterology, pediatrics, rheumatology, nutraceuticals, and foot care. Research and manufacturing capabilities are integrated to develop treatments addressing skin, gastrointestinal, respiratory, and nutritional health needs. The portfolio includes dermatological treatments, nutritional supplements, and specialized clinical formulations for patient care.
Who are the top competitors of Brinton Pharmaceuticals?
Brinton Pharmaceuticals's top competitors include LEO Pharma, Formation Bio and Arcutis.
What products or services does Brinton Pharmaceuticals offer?
Brinton Pharmaceuticals offers Therapeutic Solutions.
Who are Brinton Pharmaceuticals's investors?
Brinton Pharmaceuticals has 11 investors. Key investors include BlackSoil, India Alternatives, IDBI trustee, Tata Capital Healthcare Fund, and Suvarna Jadhav.
What is Brinton Pharmaceuticals's valuation?
The valuation of Brinton Pharmaceuticals is $36.54M as of Apr 2024.